Lisanti Capital Growth’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.72M Buy
+63,400
New +$2.66M 0.82% 57
2023
Q1
– Sell
-112,365
Closed -$2.67M – 153
2022
Q4
$2.67M Buy
+112,365
New +$2.61M 0.36% 98
2021
Q2
– Sell
-80,280
Closed -$4.32M – 162
2021
Q1
$4.32M Sell
80,280
-7,820
-9% -$450K 0.55% 76
2020
Q4
$4.31M Buy
+88,100
New +$4.08M 0.6% 74
2020
Q1
– Sell
-106,272
Closed -$2.97M – 149
2019
Q4
$2.97M Buy
+106,272
New +$2.75M 0.79% 53
2019
Q3
– Sell
-129,990
Closed -$3.71M – 126
2019
Q2
$3.71M Buy
129,990
+27,480
+27% +$686K 1.2% 36
2019
Q1
$2.56M Buy
+102,510
New +$1.96M 0.91% 50

Other funds holding VCYT

Lisanti Capital Growth's VCYT Position: Q2 2026 in Review

Lisanti Capital Growth opened a new position in Veracyte (VCYT) in Q2 2026: 63,400 shares worth $3.72M. The stake represents 0.82% of the portfolio and ranks #57 among its holdings. This is a return to the name: Lisanti Capital Growth previously reported a position in VCYT as recently as Q4 2022.

Lisanti Capital Growth first reported a position in VCYT in Q1 2019 and has held it in 7 quarters since. The position peaked at $4.32M in Q1 2021. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Lisanti Capital Growth held 63,400 shares of Veracyte worth $3.72M as of Q2 2026.
  • Veracyte was a new Lisanti Capital Growth position in Q2 2026.
  • Veracyte made up 0.82% of Lisanti Capital Growth's portfolio in Q2 2026, its #57 holding.
  • Lisanti Capital Growth first reported a position in Veracyte in Q1 2019 and has held it in 7 quarters since.
  • Lisanti Capital Growth's Veracyte position peaked at $4.32M in Q1 2021.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.